PEMBROLIZUMAB

PEMBROLIZUMAB was reported 108520 times

PEMBROLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED PANCYTOPENIA 37 0.7551
1 IMMUNE-MEDIATED HYPOTHYROIDISM 701 0.6215
2 IMMUNE-MEDIATED RENAL DISORDER 257 0.6208
3 IMMUNE-MEDIATED HYPERTHYROIDISM 156 0.6142
4 IMMUNE-MEDIATED GASTRITIS 115 0.5990
5 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 477 0.5985
6 IMMUNE-MEDIATED ADVERSE REACTION 893 0.5814
7 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 48 0.5517
8 IMMUNE-MEDIATED HEPATIC DISORDER 1047 0.5364
9 IMMUNE-MEDIATED THYROIDITIS 263 0.5324
10 IMMUNE-MEDIATED NEUROPATHY 80 0.5161
11 IMMUNE-MEDIATED OESOPHAGITIS 37 0.5139
12 IMMUNE-MEDIATED ENDOCRINOPATHY 77 0.5133
13 IMMUNE-MEDIATED PNEUMONITIS 117 0.5000
14 IMMUNE-MEDIATED PANCREATITIS 189 0.4961
15 IMMUNE-MEDIATED ARTHRITIS 187 0.4908
16 TUMOUR HYPERPROGRESSION 121 0.4879
17 IMMUNE-MEDIATED MYOCARDITIS 779 0.4821
18 IMMUNE-MEDIATED DERMATITIS 478 0.4742
19 IMMUNE-MEDIATED MYASTHENIA GRAVIS 153 0.4708
20 TRANSITIONAL CELL CARCINOMA METASTATIC 55 0.4701
21 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 104 0.4561
22 TUMOUR PSEUDOPROGRESSION 475 0.4338
23 IMMUNE-MEDIATED HYPOPHYSITIS 191 0.4235
24 IMMUNE-MEDIATED CHOLANGITIS 150 0.4178
25 IMMUNE-MEDIATED ENCEPHALITIS 217 0.4102
26 IMMUNE-MEDIATED NEPHRITIS 190 0.4051
27 IMMUNE-MEDIATED CYSTITIS 46 0.4000
28 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 343 0.3907
29 IMMUNE-MEDIATED LUNG DISEASE 686 0.3759
30 MALIGNANT NEOPLASM OLIGOPROGRESSION 73 0.3668
31 IMMUNE-MEDIATED HEPATITIS 728 0.3562
32 AUTOIMMUNE LUNG DISEASE 42 0.3559
33 AUTOIMMUNE HYPOTHYROIDISM 84 0.3529
34 IMMUNOTOXICITY 39 0.3421
35 ADRENALITIS 36 0.3364
36 SILENT THYROIDITIS 47 0.3264
37 IMMUNE-MEDIATED ENTEROCOLITIS 1153 0.3132
38 PSEUDOCELLULITIS 61 0.2850
39 IMMUNE-MEDIATED UVEITIS 51 0.2787
40 UROGENITAL FISTULA 66 0.2785
41 GLUCOCORTICOID DEFICIENCY 112 0.2648
42 AUTOIMMUNE MYOCARDITIS 54 0.2466
43 AUTOIMMUNE ARTHRITIS 38 0.2420
44 AUTOIMMUNE COLITIS 156 0.2419
45 HYPOPHYSITIS 484 0.2404
46 AUTOIMMUNE NEPHRITIS 52 0.2364
47 CERVIX CARCINOMA RECURRENT 42 0.2360
48 KL-6 INCREASED 51 0.2257
49 TUMOUR ASSOCIATED FEVER 85 0.2078
50 THROMBOPHLEBITIS MIGRANS 68 0.2000
51 BLOOD CORTICOTROPHIN DECREASED 95 0.1947
52 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 241 0.1934
53 THYROIDITIS 580 0.1929
54 RADIOTHERAPY 353 0.1844
55 PRIMARY ADRENAL INSUFFICIENCY 54 0.1770
56 MYASTHENIC SYNDROME 126 0.1628
57 SARCOID-LIKE REACTION 42 0.1628
58 LICHENOID KERATOSIS 372 0.1627
59 FULMINANT TYPE 1 DIABETES MELLITUS 153 0.1484
60 CORTISOL DECREASED 169 0.1479
61 IMMUNE-MEDIATED MYOSITIS 400 0.1450
62 BLOOD CORTICOTROPHIN INCREASED 40 0.1384
63 EOSINOPHILIC FASCIITIS 48 0.1383
64 NEPHRITIS 462 0.1382
65 LYMPHOCYTIC HYPOPHYSITIS 38 0.1377
66 ADRENAL INSUFFICIENCY 1670 0.1375
67 MELANOMA RECURRENT 56 0.1330
68 HYPOPITUITARISM 229 0.1315
69 HYPOTHALAMO-PITUITARY DISORDER 190 0.1304
70 SECONDARY ADRENOCORTICAL INSUFFICIENCY 194 0.1284
71 AUTOIMMUNE PANCREATITIS 63 0.1245
72 THERAPY PARTIAL RESPONDER 1914 0.1226
73 MALIGNANT NEOPLASM PROGRESSION 12384 0.1208
74 TYPE 1 DIABETES MELLITUS 727 0.1206
75 MYOCARDITIS 1318 0.1149
76 VASCULAR ACCESS COMPLICATION 84 0.1037
77 ADRENAL DISORDER 192 0.0999
78 VITILIGO 224 0.0954
79 HYPOTHYROIDISM 3041 0.0951
80 ENCEPHALITIS AUTOIMMUNE 116 0.0882
81 CHOLANGITIS SCLEROSING 176 0.0856
82 RADIATION NECROSIS 49 0.0855
83 PARANEOPLASTIC SYNDROME 57 0.0843
84 PNEUMONITIS 2271 0.0833
85 MYOSITIS 711 0.0792
86 CYTOKINE STORM 54 0.0788
87 LYMPHANGIOSIS CARCINOMATOSA 79 0.0758
88 RADIATION PNEUMONITIS 162 0.0756
89 TUMOUR NECROSIS 78 0.0738
90 CHOLANGITIS 455 0.0733
91 THYROID HORMONES DECREASED 58 0.0725
92 LYMPHADENECTOMY 70 0.0717
93 SKIN TOXICITY 403 0.0712
94 FEMALE GENITAL TRACT FISTULA 121 0.0708
95 ADRENOCORTICAL INSUFFICIENCY ACUTE 137 0.0701
96 HEPATIC CYTOLYSIS 893 0.0700
97 SMALL INTESTINAL PERFORATION 129 0.0687
98 MALIGNANT PLEURAL EFFUSION 116 0.0687
99 MYASTHENIA GRAVIS 549 0.0679
100 THYROID HORMONES INCREASED 68 0.0647
101 HYPERTHYROIDISM 928 0.0640
102 DUODENAL PERFORATION 62 0.0631
103 FEBRILE BONE MARROW APLASIA 261 0.0614
104 CANCER PAIN 153 0.0598
105 METASTATIC MALIGNANT MELANOMA 137 0.0596
106 PULMONARY TOXICITY 418 0.0590
107 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 105 0.0590
108 MALIGNANT ASCITES 45 0.0587
109 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 439 0.0584
110 POLYMYALGIA RHEUMATICA 184 0.0579
111 ENCEPHALITIS 395 0.0570
112 PROTEINURIA 1072 0.0563
113 TUBULOINTERSTITIAL NEPHRITIS 1055 0.0562
114 ENDOCRINE DISORDER 72 0.0561
115 INTERSTITIAL LUNG DISEASE 2630 0.0543
116 AUTOIMMUNE HEPATITIS 376 0.0540
117 AORTITIS 37 0.0539
118 COLITIS 2021 0.0533
119 IMMUNE THROMBOCYTOPENIA 244 0.0532
120 BLOOD LACTATE DEHYDROGENASE ABNORMAL 36 0.0531
121 PEMPHIGOID 392 0.0519
122 TUMOUR HAEMORRHAGE 147 0.0515
123 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1197 0.0513
124 CANCER SURGERY 48 0.0501
125 HYPERSENSITIVITY PNEUMONITIS 57 0.0500
126 GASTROINTESTINAL PERFORATION 204 0.0490
127 ENTEROCOLITIS 276 0.0478
128 LICHEN PLANUS 110 0.0474
129 TROPONIN INCREASED 357 0.0469
130 MIXED LIVER INJURY 140 0.0465
131 THYROTOXIC CRISIS 51 0.0448
132 PULMONARY SARCOIDOSIS 50 0.0445
133 TROPONIN I INCREASED 74 0.0444
134 LUNG OPACITY 117 0.0444
135 HEPATITIS 1131 0.0442
136 MYOCARDIAL INJURY 49 0.0436
137 BLOOD THYROID STIMULATING HORMONE INCREASED 396 0.0430
138 GUILLAIN-BARRE SYNDROME 207 0.0428
139 HYPERTRANSAMINASAEMIA 291 0.0418
140 THYROID DISORDER 634 0.0411
141 TOXIC EPIDERMAL NECROLYSIS 621 0.0409
142 BLOOD THYROID STIMULATING HORMONE ABNORMAL 74 0.0401
143 AMYLASE INCREASED 145 0.0393
144 AUTOIMMUNE THYROIDITIS 147 0.0388
145 ASPARTATE AMINOTRANSFERASE ABNORMAL 59 0.0387
146 TROPONIN T INCREASED 49 0.0386
147 ACQUIRED GENE MUTATION 50 0.0381
148 RENAL TUBULAR INJURY 46 0.0379
149 HEPATIC FUNCTION ABNORMAL 1400 0.0375
150 TUMOUR PAIN 49 0.0372
151 ORGANISING PNEUMONIA 184 0.0371
152 NEPHRECTOMY 55 0.0370
153 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 52 0.0370
154 PRERENAL FAILURE 52 0.0369
155 VANISHING BILE DUCT SYNDROME 41 0.0368
156 BICYTOPENIA 71 0.0362
157 AUTOIMMUNE HAEMOLYTIC ANAEMIA 123 0.0358
158 RENAL TUBULAR NECROSIS 350 0.0356
159 DERMATITIS PSORIASIFORM 72 0.0352
160 INFECTIOUS PLEURAL EFFUSION 53 0.0348
161 BILIARY OBSTRUCTION 45 0.0347
162 DERMATITIS BULLOUS 246 0.0339
163 LYMPHADENOPATHY MEDIASTINAL 65 0.0339
164 DUODENITIS 104 0.0339
165 PHYSICAL DECONDITIONING 87 0.0338
166 MASTECTOMY 59 0.0337
167 GALLBLADDER ENLARGEMENT 36 0.0334
168 CAPILLARY LEAK SYNDROME 68 0.0329
169 MENINGITIS ASEPTIC 146 0.0325
170 SIALOADENITIS 44 0.0323
171 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 36 0.0321
172 CARCINOEMBRYONIC ANTIGEN INCREASED 62 0.0320
173 RECURRENT CANCER 130 0.0318
174 BLOOD THYROID STIMULATING HORMONE DECREASED 144 0.0317
175 PROCALCITONIN INCREASED 37 0.0315
176 MYELOSUPPRESSION 1120 0.0311
177 MYELITIS TRANSVERSE 43 0.0305
178 HEPATOTOXICITY 672 0.0302
179 PANCREATIC FAILURE 53 0.0300
180 OXYGEN THERAPY 49 0.0298
181 ERYTHEMA MULTIFORME 277 0.0297
182 PNEUMONIA BACTERIAL 270 0.0294
183 ENTERITIS 188 0.0293
184 DRUG ERUPTION 515 0.0290
185 POLYARTHRITIS 152 0.0288
186 OPHTHALMOPLEGIA 45 0.0285
187 LARGE INTESTINE PERFORATION 198 0.0285
188 PERIPHERAL MOTOR NEUROPATHY 39 0.0278
189 CARDIAC TAMPONADE 132 0.0277
190 METASTASES TO MENINGES 63 0.0277
191 CARDIAC DYSFUNCTION 102 0.0274
192 LUNG ADENOCARCINOMA 82 0.0272
193 RASH MACULO-PAPULAR 605 0.0272
194 CHOLECYSTITIS 319 0.0268
195 ALANINE AMINOTRANSFERASE ABNORMAL 56 0.0265
196 CENTRAL VENOUS CATHETERISATION 80 0.0265
197 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 38 0.0264
198 INTESTINAL PERFORATION 295 0.0263
199 CYTOKINE RELEASE SYNDROME 526 0.0262
200 MUCOSAL INFLAMMATION 676 0.0258
201 MYASTHENIA GRAVIS CRISIS 38 0.0256
202 HEPATITIS CHOLESTATIC 154 0.0255
203 GASTROINTESTINAL TOXICITY 122 0.0254
204 EXTREMITY NECROSIS 44 0.0252
205 PNEUMOCYSTIS JIROVECII PNEUMONIA 252 0.0251
206 FEBRILE NEUTROPENIA 1661 0.0250
207 PANCYTOPENIA 1399 0.0250
208 DERMATOMYOSITIS 63 0.0248
209 THYROID FUNCTION TEST ABNORMAL 103 0.0248
210 STEVENS-JOHNSON SYNDROME 543 0.0244
211 CHRONIC GASTRITIS 55 0.0243
212 CHOLESTATIC LIVER INJURY 54 0.0242
213 HEPATITIS TOXIC 63 0.0242
214 GASTRITIS HAEMORRHAGIC 36 0.0241
215 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 229 0.0240
216 RHEUMATIC DISORDER 46 0.0238
217 CELL DEATH 47 0.0237
218 HAEMATOTOXICITY 224 0.0235
219 MENINGITIS 157 0.0235
220 NEUROPATHY PERIPHERAL 2221 0.0233
221 NEUTROPHIL COUNT DECREASED 938 0.0230
222 LIVER ABSCESS 74 0.0228
223 NON-SMALL CELL LUNG CANCER 109 0.0227
224 RENAL TUBULAR DISORDER 64 0.0227
225 TASTE DISORDER 461 0.0227
226 RENAL IMPAIRMENT 1879 0.0223
227 MYOCARDIAL NECROSIS MARKER INCREASED 37 0.0221
228 POLYMYOSITIS 39 0.0220
229 GASTRIC PERFORATION 60 0.0220
230 ATRIOVENTRICULAR BLOCK COMPLETE 144 0.0215
231 NEPHROPATHY TOXIC 241 0.0214
232 LUNG ABSCESS 45 0.0214
233 HEPATITIS FULMINANT 63 0.0212
234 PERIPHERAL SENSORY NEUROPATHY 124 0.0212
235 BRAIN NATRIURETIC PEPTIDE INCREASED 65 0.0211
236 CACHEXIA 108 0.0210
237 COLITIS MICROSCOPIC 99 0.0209
238 NEUTROPHIL COUNT ABNORMAL 59 0.0209
239 SKIN DISORDER 695 0.0208
240 DIABETIC KETOACIDOSIS 500 0.0208
241 CARDIOTOXICITY 185 0.0207
242 CHOLESTASIS 395 0.0206
243 IMMUNE THROMBOCYTOPENIC PURPURA 58 0.0205
244 CHOLECYSTITIS ACUTE 116 0.0205
245 NEOPLASM PROGRESSION 711 0.0204
246 STOMATITIS 1225 0.0202
247 PNEUMOTHORAX 320 0.0202
248 HYDRONEPHROSIS 150 0.0200
249 EYELID PTOSIS 203 0.0200
250 NEPHROTIC SYNDROME 136 0.0198
251 LUNG CONSOLIDATION 55 0.0196
252 PYELONEPHRITIS 170 0.0196
253 SKIN EROSION 63 0.0195
254 APLASIA PURE RED CELL 67 0.0195
255 DISSEMINATED INTRAVASCULAR COAGULATION 271 0.0192
256 SARCOIDOSIS 91 0.0191
257 RASH MORBILLIFORM 53 0.0191
258 TUMOUR LYSIS SYNDROME 166 0.0188
259 METASTASES TO CENTRAL NERVOUS SYSTEM 243 0.0188
260 BLOOD CHLORIDE DECREASED 48 0.0186
261 ILEUS 231 0.0186
262 SMALL INTESTINAL HAEMORRHAGE 37 0.0184
263 ADENOCARCINOMA 41 0.0183
264 PROTEIN URINE PRESENT 91 0.0182
265 PNEUMATOSIS INTESTINALIS 52 0.0182
266 HOSPICE CARE 180 0.0182
267 CYTOPENIA 222 0.0181
268 KERATITIS 55 0.0181
269 STRESS CARDIOMYOPATHY 105 0.0180
270 NEUTROPENIA 2450 0.0180
271 BLOOD CREATININE ABNORMAL 62 0.0179
272 AORTIC ARTERIOSCLEROSIS 46 0.0179
273 DIASTOLIC DYSFUNCTION 55 0.0178
274 PERICARDIAL EFFUSION 411 0.0178
275 CARDIAC FAILURE ACUTE 117 0.0175
276 PULSE ABNORMAL 42 0.0174
277 HYPOALBUMINAEMIA 135 0.0173
278 DERMATITIS EXFOLIATIVE GENERALISED 60 0.0172
279 ASCITES 503 0.0171
280 RASH VESICULAR 82 0.0169
281 HENOCH-SCHONLEIN PURPURA 37 0.0169
282 THROMBOCYTOPENIA 1884 0.0168
283 PLEURAL EFFUSION 1021 0.0168
284 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 64 0.0167
285 SYSTEMIC CANDIDA 42 0.0167
286 ACUTE KIDNEY INJURY 2550 0.0166
287 HAEMOGLOBIN ABNORMAL 107 0.0166
288 MULTIPLE ORGAN DYSFUNCTION SYNDROME 469 0.0165
289 PLATELET COUNT DECREASED 1757 0.0165
290 LIPASE INCREASED 126 0.0164
291 DUODENAL ULCER 116 0.0164
292 DYSPHONIA 955 0.0163
293 TOXIC SKIN ERUPTION 163 0.0162
294 CARBOHYDRATE ANTIGEN 125 INCREASED 55 0.0161
295 METASTASES TO PERITONEUM 40 0.0158
296 DIABETES INSIPIDUS 38 0.0158
297 HYPERTENSION 3339 0.0157
298 OESOPHAGITIS 172 0.0157
299 SUSPECTED OFF LABEL USE 71 0.0157
300 BREAST CANCER RECURRENT 49 0.0155
301 CARDIOMYOPATHY 229 0.0155
302 SEPTIC SHOCK 670 0.0154
303 BLOOD POTASSIUM ABNORMAL 41 0.0154
304 CEREBRAL INFARCTION 372 0.0152
305 HYPERPYREXIA 64 0.0151
306 CHEMOTHERAPY 57 0.0151
307 NEOPLASM RECURRENCE 51 0.0150
308 PERFORMANCE STATUS DECREASED 70 0.0150
309 LIVER DISORDER 665 0.0150
310 PULMONARY MASS 220 0.0148
311 C-REACTIVE PROTEIN INCREASED 536 0.0147
312 HYPOMAGNESAEMIA 205 0.0147
313 GLOMERULONEPHRITIS 36 0.0147
314 ADVERSE EVENT 1353 0.0147
315 ASPARTATE AMINOTRANSFERASE INCREASED 778 0.0146
316 DECREASED APPETITE 3399 0.0146
317 DRUG-INDUCED LIVER INJURY 459 0.0146
318 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 150 0.0146
319 PROTEIN TOTAL DECREASED 55 0.0146
320 TRANSAMINASES INCREASED 323 0.0145
321 PRODUCT USE IN UNAPPROVED INDICATION 3594 0.0145
322 INFLAMMATORY MARKER INCREASED 71 0.0143
323 IRIDOCYCLITIS 45 0.0142
324 MYOPATHY 123 0.0142
325 HEPATOCELLULAR INJURY 200 0.0141
326 LEUKOPENIA 702 0.0140
327 POLYNEUROPATHY 168 0.0140
328 KETOACIDOSIS 105 0.0140
329 HEPATITIS ACUTE 91 0.0140
330 BLOOD ALBUMIN DECREASED 111 0.0140
331 PRODUCT USE ISSUE 2622 0.0139
332 DERMATITIS 292 0.0139
333 EJECTION FRACTION DECREASED 216 0.0139
334 ALANINE AMINOTRANSFERASE INCREASED 853 0.0139
335 AGRANULOCYTOSIS 258 0.0139
336 JAUNDICE CHOLESTATIC 49 0.0139
337 EMBOLISM VENOUS 42 0.0138
338 HYPONATRAEMIA 779 0.0138
339 HYPERCALCAEMIA 170 0.0138
340 GASTROINTESTINAL NECROSIS 40 0.0137
341 ATELECTASIS 132 0.0136
342 SKIN REACTION 192 0.0136
343 HAEMOLYTIC ANAEMIA 121 0.0135
344 METASTASES TO LUNG 156 0.0135
345 PNEUMONIA ASPIRATION 337 0.0135
346 SCLERODERMA 49 0.0135
347 BLOOD MAGNESIUM DECREASED 116 0.0134
348 AUTOIMMUNE DISORDER 130 0.0133
349 PAPILLOEDEMA 60 0.0133
350 GLOSSITIS 47 0.0132
351 ANAEMIA 2514 0.0132
352 ACUTE CORONARY SYNDROME 108 0.0130
353 HYPERBILIRUBINAEMIA 135 0.0130
354 FIBRIN D DIMER INCREASED 46 0.0129
355 HYPERGLYCAEMIA 464 0.0127
356 TUMOUR MARKER INCREASED 61 0.0127
357 HYPERTHERMIA 97 0.0127
358 FACIAL PARALYSIS 108 0.0127
359 HYPERURICAEMIA 52 0.0126
360 BRAIN OEDEMA 159 0.0126
361 ACUTE RESPIRATORY FAILURE 236 0.0123
362 FEEDING DISORDER 248 0.0122
363 NEUTROPENIC SEPSIS 87 0.0122
364 ELECTROLYTE IMBALANCE 141 0.0121
365 DYSAESTHESIA 37 0.0121
366 EOSINOPHILIC PNEUMONIA 38 0.0120
367 CARDIOGENIC SHOCK 173 0.0120
368 NECROSIS 67 0.0120
369 UVEITIS 163 0.0120
370 PANCREATIC DISORDER 59 0.0120
371 ERYSIPELAS 60 0.0119
372 PLATELET COUNT ABNORMAL 72 0.0119
373 CARDIAC FAILURE 956 0.0119
374 LUMBAR VERTEBRAL FRACTURE 54 0.0118
375 OPTIC NEURITIS 107 0.0118
376 RESPIRATORY FAILURE 857 0.0117
377 LIVER FUNCTION TEST INCREASED 252 0.0117
378 VASCULITIS 136 0.0117
379 PURPURA 103 0.0116
380 PYREXIA 4018 0.0116
381 STAPHYLOCOCCAL BACTERAEMIA 50 0.0115
382 EOSINOPHILIA 201 0.0115
383 HEPATIC FAILURE 343 0.0114
384 BONE LESION 41 0.0114
385 FAILURE TO THRIVE 59 0.0114
386 HEPATIC LESION 49 0.0113
387 EMBOLISM 94 0.0113
388 ALTERED STATE OF CONSCIOUSNESS 245 0.0113
389 ENDOCARDITIS 58 0.0113
390 BLOOD BILIRUBIN INCREASED 305 0.0113
391 PERIPHERAL ISCHAEMIA 46 0.0113
392 HYPOKALAEMIA 519 0.0112
393 VENOUS THROMBOSIS 44 0.0112
394 THROMBOTIC MICROANGIOPATHY 109 0.0112
395 METASTASES TO LYMPH NODES 75 0.0111
396 AORTIC DISSECTION 46 0.0111
397 BLOOD PRESSURE ABNORMAL 219 0.0110
398 PULMONARY TUBERCULOSIS 47 0.0110
399 GRANULOMA 38 0.0110
400 SUDDEN DEATH 116 0.0110
401 LUNG DISORDER 536 0.0109
402 GENERAL PHYSICAL HEALTH DETERIORATION 1265 0.0109
403 BLOOD CREATINE INCREASED 48 0.0108
404 PATHOLOGICAL FRACTURE 55 0.0108
405 THROMBOTIC THROMBOCYTOPENIC PURPURA 38 0.0108
406 LYMPHADENOPATHY 380 0.0107
407 HAEMOPTYSIS 295 0.0106
408 RENAL FUNCTION TEST ABNORMAL 49 0.0105
409 ORAL PAIN 236 0.0105
410 BONE MARROW FAILURE 213 0.0105
411 CORONAVIRUS INFECTION 69 0.0104
412 HYPERTRIGLYCERIDAEMIA 61 0.0104
413 LYMPHOEDEMA 72 0.0104
414 APLASTIC ANAEMIA 54 0.0103
415 ACUTE RESPIRATORY DISTRESS SYNDROME 182 0.0103
416 PYODERMA GANGRENOSUM 37 0.0103
417 INFUSION SITE EXTRAVASATION 64 0.0103
418 EOSINOPHIL COUNT INCREASED 85 0.0102
419 WHITE BLOOD CELL COUNT ABNORMAL 65 0.0102
420 GENERALISED OEDEMA 126 0.0102
421 PANCREATITIS 538 0.0102
422 LEFT VENTRICULAR DYSFUNCTION 68 0.0101
423 SEPSIS 1123 0.0101
424 METASTASES TO BONE 165 0.0100
425 BLOOD SODIUM DECREASED 189 0.0100
426 HEPATIC ENZYME INCREASED 679 0.0100
427 IMMUNE SYSTEM DISORDER 131 0.0099
428 NAIL DISCOLOURATION 39 0.0099
429 SMALL INTESTINAL OBSTRUCTION 122 0.0099
430 BLOOD CREATININE INCREASED 647 0.0099
431 CUTANEOUS VASCULITIS 36 0.0099
432 PULMONARY EMBOLISM 935 0.0098
433 HEPATIC ENZYME ABNORMAL 49 0.0098
434 CHEILITIS 53 0.0098
435 ISCHAEMIA 45 0.0098
436 PLEURISY 58 0.0098
437 ENCEPHALOPATHY 239 0.0097
438 HEPATIC ENCEPHALOPATHY 90 0.0096
439 PERICARDITIS 162 0.0096
440 RED CELL DISTRIBUTION WIDTH INCREASED 40 0.0096
441 NEUROLOGICAL SYMPTOM 55 0.0096
442 HYPOCALCAEMIA 182 0.0096
443 MALNUTRITION 107 0.0096
444 AZOTAEMIA 38 0.0095
445 HYPOPHAGIA 241 0.0094
446 HYPERKERATOSIS 52 0.0094
447 BLOOD LACTATE DEHYDROGENASE INCREASED 148 0.0093
448 NEUROTOXICITY 163 0.0093
449 METASTASES TO LIVER 163 0.0093
450 INTESTINAL ISCHAEMIA 51 0.0093
451 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1654 0.0092
452 DIARRHOEA 5920 0.0092
453 CLOSTRIDIUM DIFFICILE COLITIS 97 0.0091
454 SECOND PRIMARY MALIGNANCY 76 0.0091
455 EMPHYSEMA 92 0.0091
456 GINGIVITIS 49 0.0091
457 HYPOXIA 319 0.0090
458 LUNG INFILTRATION 80 0.0090
459 APPETITE DISORDER 60 0.0090
460 VASCULAR DEVICE INFECTION 41 0.0090
461 HYPOVOLAEMIC SHOCK 43 0.0090
462 SQUAMOUS CELL CARCINOMA OF SKIN 54 0.0089
463 BLOOD ALKALINE PHOSPHATASE INCREASED 222 0.0089
464 CEREBRAL ISCHAEMIA 46 0.0089
465 GASTRITIS 235 0.0089
466 BLOOD CREATINE PHOSPHOKINASE INCREASED 257 0.0089
467 RASH 3883 0.0089
468 DISEASE PROGRESSION 1053 0.0089
469 GAMMA-GLUTAMYLTRANSFERASE INCREASED 197 0.0089
470 RASH PRURITIC 480 0.0088
471 ISCHAEMIC STROKE 157 0.0088
472 COLITIS ISCHAEMIC 59 0.0087
473 LIP OEDEMA 37 0.0087
474 TONGUE DISCOMFORT 37 0.0087
475 BLOOD PRESSURE DIASTOLIC INCREASED 40 0.0087
476 PARONYCHIA 38 0.0086
477 METASTASIS 61 0.0085
478 DEHYDRATION 1135 0.0085
479 GASTROINTESTINAL MOTILITY DISORDER 45 0.0084
480 HICCUPS 69 0.0084
481 TRANSFUSION 88 0.0084
482 ABDOMINAL ABSCESS 37 0.0084
483 MALIGNANT MELANOMA 112 0.0084
484 ARTERIOSCLEROSIS CORONARY ARTERY 55 0.0083
485 PULMONARY FIBROSIS 159 0.0083
486 LYMPHOPENIA 117 0.0083
487 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 64 0.0082
488 DIABETES MELLITUS 623 0.0082
489 SHOCK HAEMORRHAGIC 66 0.0081
490 STAPHYLOCOCCAL SEPSIS 40 0.0081
491 GASTRIC ULCER 153 0.0080
492 BLOOD PRESSURE INCREASED 1216 0.0079
493 C-REACTIVE PROTEIN ABNORMAL 51 0.0079
494 THERAPY NON-RESPONDER 356 0.0079
495 ARTERIOSCLEROSIS 74 0.0079
496 ORAL DISORDER 57 0.0078
497 RENAL FAILURE 1031 0.0078
498 DERMATITIS ACNEIFORM 47 0.0077
499 HAEMATURIA 264 0.0077
500 DYSPHAGIA 731 0.0077
501 ACUTE MYELOID LEUKAEMIA 120 0.0077
502 PULMONARY ALVEOLAR HAEMORRHAGE 43 0.0077
503 PANCREATITIS ACUTE 172 0.0076
504 FISTULA 86 0.0076
505 ASTHENIA 2865 0.0076
506 PIGMENTATION DISORDER 47 0.0076
507 ORAL CANDIDIASIS 100 0.0076
508 SPINAL COMPRESSION FRACTURE 62 0.0075
509 BRONCHOPULMONARY ASPERGILLOSIS 58 0.0075
510 FLANK PAIN 70 0.0075
511 BLOOD UREA INCREASED 125 0.0075
512 LARYNGEAL OEDEMA 46 0.0075
513 DRY MOUTH 605 0.0074
514 HYPERKALAEMIA 260 0.0074
515 WEIGHT FLUCTUATION 77 0.0074
516 ILL-DEFINED DISORDER 445 0.0073
517 DYSPNOEA EXERTIONAL 275 0.0073
518 LIVER INJURY 177 0.0072
519 DELIRIUM 249 0.0072
520 BLOOD PRESSURE FLUCTUATION 172 0.0072
521 BLISTER 399 0.0071
522 COMPRESSION FRACTURE 38 0.0071
523 PNEUMONIA 2292 0.0071
524 BACTERAEMIA 84 0.0071
525 ACUTE MYOCARDIAL INFARCTION 208 0.0070
526 BLOOD CALCIUM DECREASED 79 0.0070
527 DEVICE RELATED INFECTION 108 0.0070
528 DEATH 6043 0.0070
529 OEDEMA 380 0.0070
530 PERITONITIS 145 0.0070
531 GENERAL PHYSICAL CONDITION ABNORMAL 47 0.0069
532 CANDIDA INFECTION 117 0.0069
533 HYPERTENSIVE CRISIS 77 0.0069
534 GASTROINTESTINAL INFLAMMATION 54 0.0069
535 AGEUSIA 171 0.0068
536 DRUG RESISTANCE 176 0.0068
537 UROSEPSIS 63 0.0068
538 DIPLOPIA 177 0.0068
539 CONSTIPATION 1477 0.0068
540 ASPIRATION 74 0.0067
541 INTESTINAL OBSTRUCTION 254 0.0067
542 WEIGHT DECREASED 1881 0.0067
543 FAECES SOFT 49 0.0067
544 FATIGUE 5236 0.0067
545 GROIN PAIN 59 0.0067
546 LEUKOCYTOSIS 121 0.0067
547 SUBARACHNOID HAEMORRHAGE 68 0.0067
548 SHOCK 153 0.0066
549 NEUTROPHIL COUNT INCREASED 68 0.0066
550 RENAL DISORDER 309 0.0066
551 WHITE BLOOD CELL COUNT DECREASED 710 0.0065
552 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 54 0.0065
553 PULMONARY HAEMORRHAGE 51 0.0065
554 RASH PAPULAR 146 0.0065
555 CEREBRAL HAEMORRHAGE 232 0.0065
556 VENTRICULAR TACHYCARDIA 107 0.0065
557 JAUNDICE 174 0.0065
558 ABNORMAL LOSS OF WEIGHT 44 0.0064
559 LYMPHOCYTE COUNT DECREASED 114 0.0064
560 GAIT INABILITY 215 0.0064
561 DECREASED ACTIVITY 69 0.0064
562 APHONIA 89 0.0064
563 SPINAL OSTEOARTHRITIS 56 0.0064
564 ODYNOPHAGIA 38 0.0064
565 PRODUCT PRESCRIBING ISSUE 138 0.0063
566 RESPIRATORY DISTRESS 174 0.0063
567 EATING DISORDER 133 0.0062
568 MYALGIA 1061 0.0062
569 HAEMOLYSIS 48 0.0062
570 ATRIOVENTRICULAR BLOCK 48 0.0062
571 DIARRHOEA HAEMORRHAGIC 58 0.0062
572 RETINAL DETACHMENT 57 0.0062
573 ADVERSE REACTION 82 0.0062
574 FACE OEDEMA 104 0.0062
575 ANAPHYLACTIC SHOCK 159 0.0062
576 INABILITY TO AFFORD MEDICATION 61 0.0061
577 ATRIAL FLUTTER 49 0.0061
578 COVID-19 PNEUMONIA 72 0.0061
579 BRONCHIECTASIS 41 0.0061
580 SKIN ULCER 157 0.0061
581 INFUSION RELATED REACTION 402 0.0061
582 NASAL DRYNESS 38 0.0061
583 MUSCULAR WEAKNESS 688 0.0060
584 DECUBITUS ULCER 49 0.0060
585 BRAIN FOG 94 0.0060
586 MOUTH ULCERATION 125 0.0059
587 RENAL CYST 47 0.0059
588 ACIDOSIS 45 0.0059
589 THIRST 105 0.0059
590 MOUTH HAEMORRHAGE 43 0.0059
591 MELAENA 129 0.0059
592 SUPRAVENTRICULAR TACHYCARDIA 56 0.0058
593 NEOPLASM 67 0.0058
594 EPISTAXIS 435 0.0058
595 CYTOMEGALOVIRUS INFECTION 96 0.0058
596 PROCTALGIA 37 0.0057
597 TRANSPLANT REJECTION 46 0.0057
598 ATRIAL FIBRILLATION 558 0.0057
599 ATAXIA 68 0.0057
600 PSEUDOMONAS INFECTION 49 0.0057
601 DIABETES MELLITUS INADEQUATE CONTROL 101 0.0057
602 SCAB 65 0.0057
603 ARTHRITIS 447 0.0057
604 PAPULE 40 0.0057
605 GINGIVAL PAIN 45 0.0056
606 GASTROENTERITIS 82 0.0056
607 MUSCLE ATROPHY 71 0.0056
608 MALAISE 2455 0.0056
609 OFF LABEL USE 4866 0.0056
610 DEEP VEIN THROMBOSIS 360 0.0055
611 RED BLOOD CELL COUNT DECREASED 157 0.0055
612 VENTRICULAR EXTRASYSTOLES 57 0.0055
613 BLOOD TEST ABNORMAL 77 0.0055
614 INFLAMMATION 280 0.0054
615 SINUS TACHYCARDIA 77 0.0054
616 HYPOPHOSPHATAEMIA 40 0.0054
617 OEDEMA PERIPHERAL 659 0.0054
618 NAIL DISORDER 47 0.0054
619 PULMONARY OEDEMA 240 0.0054
620 RHABDOMYOLYSIS 223 0.0053
621 FRUSTRATION TOLERANCE DECREASED 43 0.0053
622 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 154 0.0053
623 APPENDICITIS 49 0.0052
624 BLOOD DISORDER 42 0.0052
625 MOTOR DYSFUNCTION 53 0.0052
626 SKIN LESION 142 0.0052
627 COLITIS ULCERATIVE 231 0.0052
628 WHITE BLOOD CELL COUNT INCREASED 198 0.0052
629 URINARY TRACT INFECTION 877 0.0051
630 LOWER GASTROINTESTINAL HAEMORRHAGE 38 0.0051
631 MOVEMENT DISORDER 165 0.0051
632 BLOOD CALCIUM INCREASED 45 0.0051
633 POLYURIA 42 0.0051
634 UPPER GASTROINTESTINAL HAEMORRHAGE 86 0.0051
635 BLOOD POTASSIUM DECREASED 153 0.0051
636 MUSCLE DISORDER 41 0.0051
637 ABDOMINAL PAIN 1177 0.0051
638 NODULE 66 0.0051
639 ACUTE HEPATIC FAILURE 69 0.0050
640 REBOUND EFFECT 57 0.0050
641 PHOTOSENSITIVITY REACTION 83 0.0050
642 BLOOD PRESSURE DECREASED 331 0.0050
643 HEMIPARESIS 84 0.0050
644 VOMITING 2324 0.0049
645 HYPOTENSION 988 0.0049
646 CLOSTRIDIUM DIFFICILE INFECTION 107 0.0049
647 EPILEPSY 149 0.0049
648 BLOOD PRESSURE SYSTOLIC INCREASED 95 0.0049
649 CEREBRAL DISORDER 36 0.0049
650 CONJUNCTIVITIS 90 0.0048
651 OXYGEN SATURATION DECREASED 272 0.0048
652 URINARY RETENTION 160 0.0048
653 MUSCULOSKELETAL CHEST PAIN 74 0.0048
654 SQUAMOUS CELL CARCINOMA 45 0.0048
655 HEPATIC STEATOSIS 89 0.0048
656 INSURANCE ISSUE 73 0.0048
657 RESPIRATORY TRACT INFECTION 124 0.0048
658 PRURITUS 1825 0.0047
659 ARTHRALGIA 1973 0.0047
660 NERVOUS SYSTEM DISORDER 148 0.0047
661 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 260 0.0047
662 DYSURIA 174 0.0047
663 CELLULITIS 237 0.0047
664 CARDIO-RESPIRATORY ARREST 196 0.0047
665 ASPHYXIA 38 0.0047
666 RASH ERYTHEMATOUS 222 0.0046
667 NAUSEA 3672 0.0046
668 ECZEMA 242 0.0046
669 GINGIVAL BLEEDING 63 0.0046
670 LIVER FUNCTION TEST ABNORMAL 134 0.0046
671 CHILLS 538 0.0046
672 GLOSSODYNIA 102 0.0046
673 GASTROINTESTINAL DISORDER 408 0.0045
674 BONE PAIN 266 0.0045
675 HAEMATOCRIT DECREASED 90 0.0045
676 ORAL DISCOMFORT 63 0.0045
677 CIRCULATORY COLLAPSE 77 0.0045
678 ABNORMAL FAECES 37 0.0045
679 IMPAIRED HEALING 148 0.0045
680 MYOCARDIAL ISCHAEMIA 51 0.0045
681 SKIN INFECTION 50 0.0045
682 INFECTION 645 0.0045
683 FEELING COLD 124 0.0044
684 HAEMOGLOBIN DECREASED 455 0.0044
685 NEPHROPATHY 41 0.0044
686 INCORRECT PRODUCT ADMINISTRATION DURATION 95 0.0044
687 METABOLIC ACIDOSIS 140 0.0044
688 BLOOD POTASSIUM INCREASED 71 0.0044
689 DERMATITIS ALLERGIC 55 0.0044
690 IMMUNOSUPPRESSION 38 0.0043
691 BLOOD GLUCOSE ABNORMAL 79 0.0043
692 DYSPNOEA 2418 0.0043
693 PARALYSIS 61 0.0043
694 NEURALGIA 103 0.0042
695 BACTERIAL INFECTION 79 0.0042
696 LUPUS-LIKE SYNDROME 38 0.0042
697 MYELODYSPLASTIC SYNDROME 60 0.0041
698 COUGH 1156 0.0041
699 OSTEONECROSIS OF JAW 102 0.0041
700 PETECHIAE 43 0.0041
701 DYSSTASIA 120 0.0041
702 ARRHYTHMIA 192 0.0041
703 DYSARTHRIA 152 0.0040
704 CARDIAC ARREST 333 0.0040
705 BRAIN NEOPLASM 37 0.0040
706 RASH MACULAR 140 0.0040
707 HERPES ZOSTER 230 0.0040
708 GASTRIC HAEMORRHAGE 46 0.0040
709 HEPATIC CIRRHOSIS 75 0.0040
710 COGNITIVE DISORDER 186 0.0040
711 PRODUCTIVE COUGH 189 0.0040
712 HYPOTHERMIA 40 0.0039
713 TYPE 2 DIABETES MELLITUS 133 0.0039
714 CYSTITIS 125 0.0039
715 APHASIA 118 0.0039
716 VITREOUS FLOATERS 38 0.0039
717 MENTAL STATUS CHANGES 107 0.0038
718 DRY EYE 192 0.0038
719 DYSGEUSIA 285 0.0038
720 SEIZURE 443 0.0038
721 PLATELET COUNT INCREASED 50 0.0038
722 HAEMATEMESIS 96 0.0038
723 ERYTHEMA 778 0.0038
724 POOR VENOUS ACCESS 39 0.0038
725 SPINAL PAIN 44 0.0038
726 NO ADVERSE EVENT 677 0.0037
727 SURGERY 218 0.0037
728 GASTROINTESTINAL HAEMORRHAGE 310 0.0037
729 LABORATORY TEST ABNORMAL 109 0.0037
730 INCONTINENCE 39 0.0037
731 DEMENTIA 103 0.0037
732 POOR QUALITY SLEEP 79 0.0037
733 TOXICITY TO VARIOUS AGENTS 618 0.0037
734 HEPATOMEGALY 36 0.0037
735 HAEMATOCHEZIA 202 0.0037
736 TACHYCARDIA 325 0.0037
737 THROMBOSIS 294 0.0037
738 CARPAL TUNNEL SYNDROME 51 0.0036
739 SARS-COV-2 TEST POSITIVE 48 0.0036
740 SKIN EXFOLIATION 306 0.0036
741 LYMPHOMA 56 0.0036
742 RHEUMATOID ARTHRITIS 406 0.0036
743 ANAPHYLACTIC REACTION 197 0.0036
744 HAEMORRHAGE INTRACRANIAL 53 0.0035
745 CONFUSIONAL STATE 569 0.0035
746 DEPRESSED LEVEL OF CONSCIOUSNESS 139 0.0035
747 DRUG INTOLERANCE 339 0.0035
748 BACK PAIN 811 0.0035
749 DIVERTICULITIS 96 0.0035
750 RECTAL HAEMORRHAGE 147 0.0034
751 GLOMERULAR FILTRATION RATE DECREASED 42 0.0034
752 TRANSIENT ISCHAEMIC ATTACK 115 0.0034
753 ALOPECIA 667 0.0034
754 BLOOD URINE PRESENT 64 0.0034
755 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86 0.0033
756 VENTRICULAR FIBRILLATION 37 0.0033
757 FULL BLOOD COUNT DECREASED 67 0.0033
758 IMMUNODEFICIENCY 49 0.0033
759 LACRIMATION INCREASED 99 0.0033
760 STATUS EPILEPTICUS 37 0.0033
761 CENTRAL NERVOUS SYSTEM LESION 45 0.0033
762 MUSCULOSKELETAL PAIN 170 0.0032
763 COAGULOPATHY 54 0.0032
764 PERIPHERAL SWELLING 499 0.0032
765 HAEMORRHOIDS 63 0.0032
766 HYPOGLYCAEMIA 156 0.0032
767 OSTEOMYELITIS 58 0.0032
768 SPEECH DISORDER 166 0.0032
769 LUNG INFECTION 49 0.0032
770 MASS 44 0.0031
771 FAECES DISCOLOURED 68 0.0031
772 COVID-19 549 0.0031
773 DRY SKIN 416 0.0031
774 PULMONARY CONGESTION 41 0.0031
775 HYPOAESTHESIA 465 0.0031
776 ADVERSE DRUG REACTION 278 0.0031
777 CARDIOMEGALY 38 0.0031
778 THERAPEUTIC RESPONSE UNEXPECTED 138 0.0031
779 SUBDURAL HAEMATOMA 44 0.0031
780 ANGINA PECTORIS 88 0.0031
781 QUALITY OF LIFE DECREASED 41 0.0031
782 PALLOR 83 0.0030
783 ORTHOSTATIC HYPOTENSION 53 0.0030
784 LUNG NEOPLASM MALIGNANT 125 0.0030
785 BODY TEMPERATURE INCREASED 62 0.0030
786 FRACTURE 57 0.0030
787 ABDOMINAL PAIN LOWER 76 0.0030
788 DEAFNESS 78 0.0030
789 URINARY INCONTINENCE 88 0.0030
790 HYPERSOMNIA 85 0.0030
791 GENERALISED TONIC-CLONIC SEIZURE 49 0.0030
792 MUSCULOSKELETAL DISORDER 56 0.0029
793 TACHYPNOEA 40 0.0029
794 LETHARGY 169 0.0029
795 CHEST PAIN 543 0.0029
796 CHROMATURIA 66 0.0029
797 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 152 0.0029
798 COLON CANCER 43 0.0029
799 ABSCESS 46 0.0029
800 STAPHYLOCOCCAL INFECTION 95 0.0029
801 ELECTROCARDIOGRAM QT PROLONGED 103 0.0029
802 GAIT DISTURBANCE 541 0.0028
803 JOINT STIFFNESS 74 0.0028
804 GOUT 50 0.0028
805 RASH GENERALISED 72 0.0028
806 ULCER 44 0.0028
807 SKIN DISCOLOURATION 126 0.0027
808 BEDRIDDEN 36 0.0027
809 POLLAKIURIA 114 0.0027
810 HAEMORRHAGE 285 0.0027
811 CHOLELITHIASIS 89 0.0027
812 UNRESPONSIVE TO STIMULI 70 0.0027
813 PAIN IN EXTREMITY 793 0.0027
814 NECK PAIN 150 0.0027
815 BALANCE DISORDER 231 0.0027
816 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 190 0.0027
817 THERAPY CESSATION 136 0.0026
818 PRESYNCOPE 64 0.0026
819 FUNGAL INFECTION 87 0.0026
820 RESPIRATORY DISORDER 78 0.0026
821 CYANOSIS 41 0.0026
822 SPINAL FRACTURE 52 0.0026
823 DYSPEPSIA 254 0.0026
824 CEREBROVASCULAR ACCIDENT 436 0.0026
825 ABDOMINAL PAIN UPPER 528 0.0026
826 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 123 0.0026
827 DISORIENTATION 100 0.0025
828 OROPHARYNGEAL PAIN 228 0.0025
829 TREATMENT FAILURE 204 0.0025
830 PSORIASIS 321 0.0025
831 PARAESTHESIA 386 0.0025
832 HEART RATE DECREASED 86 0.0024
833 CORONARY ARTERY DISEASE 74 0.0024
834 TOOTHACHE 44 0.0024
835 SYNCOPE 242 0.0024
836 NEOPLASM MALIGNANT 161 0.0024
837 CONDITION AGGRAVATED 731 0.0024
838 NIGHT SWEATS 77 0.0024
839 CHEST DISCOMFORT 241 0.0024
840 ILLNESS 241 0.0023
841 SOMNOLENCE 471 0.0023
842 BLINDNESS 95 0.0023
843 ORAL HERPES 45 0.0023
844 FEAR 62 0.0023
845 TOOTH DISORDER 51 0.0023
846 PAIN 1389 0.0023
847 VISUAL IMPAIRMENT 279 0.0022
848 POST PROCEDURAL COMPLICATION 43 0.0022
849 DEPRESSED MOOD 118 0.0022
850 FLATULENCE 126 0.0022
851 MUSCULOSKELETAL DISCOMFORT 38 0.0022
852 HEADACHE 1381 0.0022
853 EYE DISORDER 72 0.0022
854 MYOCARDIAL INFARCTION 382 0.0022
855 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37 0.0022
856 BLOOD TRIGLYCERIDES INCREASED 38 0.0021
857 SYSTEMIC LUPUS ERYTHEMATOSUS 76 0.0021
858 SLEEP DISORDER 151 0.0021
859 PHOTOPHOBIA 40 0.0021
860 PAIN OF SKIN 57 0.0021
861 LOSS OF CONSCIOUSNESS 271 0.0021
862 FREQUENT BOWEL MOVEMENTS 57 0.0021
863 VISUAL ACUITY REDUCED 69 0.0021
864 GALLBLADDER DISORDER 37 0.0021
865 RETCHING 44 0.0021
866 GLYCOSYLATED HAEMOGLOBIN INCREASED 52 0.0021
867 BRADYCARDIA 109 0.0021
868 INCREASED APPETITE 39 0.0020
869 ABDOMINAL DISTENSION 213 0.0020
870 HOSPITALISATION 313 0.0020
871 DRUG INEFFECTIVE 2660 0.0020
872 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68 0.0020
873 HEART RATE INCREASED 199 0.0020
874 URTICARIA 336 0.0020
875 WOUND 56 0.0020
876 VISION BLURRED 275 0.0020
877 RIB FRACTURE 41 0.0020
878 KIDNEY INFECTION 39 0.0020
879 RHINORRHOEA 128 0.0020
880 DRUG INTERACTION 313 0.0020
881 PULMONARY HYPERTENSION 41 0.0020
882 CHRONIC KIDNEY DISEASE 149 0.0020
883 CARDIAC DISORDER 183 0.0020
884 RENAL INJURY 58 0.0020
885 UNDERDOSE 141 0.0019
886 LIP SWELLING 64 0.0019
887 ANGIOEDEMA 85 0.0019
888 ABDOMINAL DISCOMFORT 320 0.0019
889 MOBILITY DECREASED 137 0.0019
890 EAR PAIN 37 0.0019
891 BLOOD GLUCOSE INCREASED 355 0.0019
892 LIMB INJURY 51 0.0019
893 LIMB DISCOMFORT 58 0.0019
894 SWOLLEN TONGUE 58 0.0019
895 VAGINAL HAEMORRHAGE 80 0.0018
896 GASTROOESOPHAGEAL REFLUX DISEASE 148 0.0018
897 LOWER RESPIRATORY TRACT INFECTION 83 0.0018
898 CARDIAC FAILURE CONGESTIVE 146 0.0018
899 CARDIOVASCULAR DISORDER 46 0.0018
900 DIZZINESS 899 0.0018
901 PRODUCT AVAILABILITY ISSUE 41 0.0018
902 PRODUCT DOSE OMISSION ISSUE 524 0.0018
903 JOINT SWELLING 214 0.0018
904 VERTIGO 108 0.0018
905 SWELLING 165 0.0018
906 PSORIATIC ARTHROPATHY 71 0.0017
907 TREMOR 289 0.0017
908 MEMORY IMPAIRMENT 239 0.0017
909 SWELLING FACE 113 0.0017
910 FALL 571 0.0017
911 VIRAL INFECTION 57 0.0017
912 HOT FLUSH 129 0.0017
913 FEELING ABNORMAL 409 0.0017
914 INCORRECT DOSE ADMINISTERED 389 0.0017
915 MENTAL IMPAIRMENT 41 0.0017
916 MENTAL DISORDER 73 0.0017
917 DISTURBANCE IN ATTENTION 90 0.0017
918 AMNESIA 108 0.0017
919 HYPERSENSITIVITY 308 0.0017
920 COMA 79 0.0017
921 INSOMNIA 441 0.0017
922 INFLUENZA LIKE ILLNESS 136 0.0017
923 DISEASE RECURRENCE 78 0.0016
924 PALPITATIONS 192 0.0016
925 WEIGHT INCREASED 365 0.0016
926 PAIN IN JAW 46 0.0016
927 FLUSHING 163 0.0016
928 MUSCULOSKELETAL STIFFNESS 140 0.0016
929 PRODUCT PRESCRIBING ERROR 38 0.0016
930 TINNITUS 73 0.0016
931 LOCALISED INFECTION 38 0.0016
932 UPPER RESPIRATORY TRACT INFECTION 72 0.0016
933 MUSCLE SPASMS 285 0.0016
934 CATARACT 90 0.0015
935 OSTEOARTHRITIS 64 0.0015
936 OSTEOPOROSIS 61 0.0015
937 HAEMATOMA 38 0.0015
938 ARTHROPATHY 81 0.0015
939 RESTLESSNESS 53 0.0014
940 PROCEDURAL PAIN 40 0.0014
941 HYPOACUSIS 61 0.0014
942 INFLUENZA 156 0.0014
943 HEAD INJURY 44 0.0014
944 ANGER 47 0.0014
945 FEMUR FRACTURE 43 0.0014
946 HYPERHIDROSIS 178 0.0014
947 PRODUCT DOSE OMISSION 90 0.0014
948 NASAL CONGESTION 81 0.0014
949 WHEEZING 81 0.0014
950 DISCOMFORT 83 0.0014
951 GASTRIC DISORDER 46 0.0013
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 92 0.0013
953 BLOOD GLUCOSE DECREASED 62 0.0013
954 ANXIETY 364 0.0013
955 FEELING HOT 77 0.0013
956 EYE PAIN 69 0.0012
957 OCULAR HYPERAEMIA 58 0.0012
958 HALLUCINATION 91 0.0012
959 FLUID RETENTION 61 0.0012
960 INTENTIONAL PRODUCT USE ISSUE 105 0.0012
961 OSTEONECROSIS 39 0.0012
962 HIP FRACTURE 38 0.0012
963 THROAT IRRITATION 53 0.0012
964 THERAPEUTIC RESPONSE DECREASED 69 0.0011
965 SKIN IRRITATION 52 0.0011
966 BURNING SENSATION 79 0.0011
967 AGITATION 82 0.0011
968 NEPHROLITHIASIS 51 0.0011
969 EYE SWELLING 41 0.0011
970 THERAPY INTERRUPTED 78 0.0011
971 CONTUSION 105 0.0011
972 SINUSITIS 110 0.0011
973 PLASMA CELL MYELOMA 41 0.0010
974 DEPRESSION 233 0.0010
975 NASOPHARYNGITIS 187 0.0010
976 BRONCHITIS 74 0.0010
977 BLOOD CHOLESTEROL INCREASED 44 0.0009
978 THERAPEUTIC PRODUCT EFFECT DECREASED 39 0.0009
979 TREATMENT NONCOMPLIANCE 46 0.0008
980 ACNE 60 0.0008
981 SKIN BURNING SENSATION 55 0.0008
982 NERVOUSNESS 40 0.0008
983 ASTHMA 86 0.0008
984 MIGRAINE 70 0.0007
985 IRRITABILITY 43 0.0007
986 UNEVALUABLE EVENT 46 0.0006
987 DRUG DOSE OMISSION 97 0.0006
988 MATERNAL EXPOSURE DURING PREGNANCY 43 0.0005
989 INTENTIONAL PRODUCT MISUSE 42 0.0005
990 BREAST CANCER 37 0.0004
991 ACCIDENTAL EXPOSURE TO PRODUCT 39 0.0004
992 OVERDOSE 81 0.0004
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 61 0.0003